APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biopharmaceutical Oral Drug Delivery

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Biopharmaceutical Oral Drug Delivery Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

23 December 2025197 pages

Choose your research edition.

Industry ResearchBiopharmaceutical Oral Drug Delivery Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Biopharmaceutical Oral Drug Delivery Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Biopharmaceutical Oral Drug Delivery Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biopharmaceutical Oral Drug Delivery Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Biopharmaceutical Oral Drug Delivery Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Biopharmaceutical Oral Drug Delivery market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Biopharmaceutical Oral Drug Delivery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Biopharmaceutical Oral Drug Delivery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biopharmaceutical Oral Drug Delivery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Biopharmaceutical Oral Drug Delivery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Biopharmaceutical Oral Drug Delivery include Sanofi, Novartis, Novo Nordisk, Pfizer, Amgen, AbbVie, Kemwell Bipharma, F. Hoffman-La Roche and Catalent, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Biopharmaceutical Oral Drug Delivery market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Biopharmaceutical Oral Drug Delivery and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Biopharmaceutical Oral Drug Delivery sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Biopharmaceutical Oral Drug Delivery market size, projected growth trends, production technologies, key applications, and end-use industries.

Biopharmaceutical Oral Drug Delivery Segment by Company

Sanofi

Novartis

Novo Nordisk

Pfizer

Amgen

AbbVie

Kemwell Bipharma

F. Hoffman-La Roche

Catalent

Biocon

Biopharmaceutical Oral Drug Delivery Segment by Type

Normally Protein (Antibodies)

Nucleic Acids (DNA, RNA Or Oligonucleotides)

Biopharmaceutical Oral Drug Delivery Segment by Application

Retail Pharmacy

Hospital Pharmacy

Specialty Pharmacy

Biopharmaceutical Oral Drug Delivery Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biopharmaceutical Oral Drug Delivery market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biopharmaceutical Oral Drug Delivery and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biopharmaceutical Oral Drug Delivery.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Biopharmaceutical Oral Drug Delivery market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Biopharmaceutical Oral Drug Delivery manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Biopharmaceutical Oral Drug Delivery in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Biopharmaceutical Oral Drug Delivery in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Biopharmaceutical Oral Drug Delivery Industry Trends Table 2. Biopharmaceutical Oral Drug Delivery Industry Drivers Table 3. Biopharmaceutical Oral Drug Delivery Industry Opportunities and Challenges Table 4. Biopharmaceutical Oral Drug Delivery Industry Restraints Table 5. Global Biopharmaceutical Oral Drug Delivery Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Biopharmaceutical Oral Drug Delivery Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Biopharmaceutical Oral Drug Delivery Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Biopharmaceutical Oral Drug Delivery Sales Market Share by Manufacturers Table 9. Global Biopharmaceutical Oral Drug Delivery Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Biopharmaceutical Oral Drug Delivery Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Biopharmaceutical Oral Drug Delivery Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Biopharmaceutical Oral Drug Delivery Manufacturers, Product Type & Application Table 13. Global Biopharmaceutical Oral Drug Delivery Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Biopharmaceutical Oral Drug Delivery by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Normally Protein (Antibodies) Table 17. Major Manufacturers of Nucleic Acids (DNA, RNA Or Oligonucleotides) Table 18. Global Biopharmaceutical Oral Drug Delivery Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Biopharmaceutical Oral Drug Delivery Sales by Type (2021-2026) & (k units) Table 20. Global Biopharmaceutical Oral Drug Delivery Sales by Type (2027-2032) & (k units) Table 21. Global Biopharmaceutical Oral Drug Delivery Sales Market Share by Type (2021-2026) Table 22. Global Biopharmaceutical Oral Drug Delivery Sales Market Share by Type (2027-2032) Table 23. Global Biopharmaceutical Oral Drug Delivery Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Biopharmaceutical Oral Drug Delivery Revenue by Type (2021-2026) & (k units) Table 25. Global Biopharmaceutical Oral Drug Delivery Revenue by Type (2027-2032) & (k units) Table 26. Global Biopharmaceutical Oral Drug Delivery Revenue Market Share by Type (2021-2026) Table 27. Global Biopharmaceutical Oral Drug Delivery Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Retail Pharmacy Table 29. Major Manufacturers of Hospital Pharmacy Table 30. Major Manufacturers of Specialty Pharmacy Table 31. Global Biopharmaceutical Oral Drug Delivery Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Biopharmaceutical Oral Drug Delivery Sales by Application (2021-2026) & (k units) Table 33. Global Biopharmaceutical Oral Drug Delivery Sales by Application (2027-2032) & (k units) Table 34. Global Biopharmaceutical Oral Drug Delivery Sales Market Share by Application (2021-2026) Table 35. Global Biopharmaceutical Oral Drug Delivery Sales Market Share by Application (2027-2032) Table 36. Global Biopharmaceutical Oral Drug Delivery Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Biopharmaceutical Oral Drug Delivery Revenue by Application (2021-2026) & (k units) Table 38. Global Biopharmaceutical Oral Drug Delivery Revenue by Application (2027-2032) & (k units) Table 39. Global Biopharmaceutical Oral Drug Delivery Revenue Market Share by Application (2021-2026) Table 40. Global Biopharmaceutical Oral Drug Delivery Revenue Market Share by Application (2027-2032) Table 41. Global Biopharmaceutical Oral Drug Delivery Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Biopharmaceutical Oral Drug Delivery Sales by Region (2021-2026) & (k units) Table 43. Global Biopharmaceutical Oral Drug Delivery Sales Market Share by Region (2021-2026) Table 44. Global Biopharmaceutical Oral Drug Delivery Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Biopharmaceutical Oral Drug Delivery Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Biopharmaceutical Oral Drug Delivery Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Biopharmaceutical Oral Drug Delivery Sales by Country (2021-2026) & (k units) Table 48. North America Biopharmaceutical Oral Drug Delivery Sales by Country (2027-2032) & (k units) Table 49. Europe Biopharmaceutical Oral Drug Delivery Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Biopharmaceutical Oral Drug Delivery Sales by Country (2021-2026) & (k units) Table 51. Europe Biopharmaceutical Oral Drug Delivery Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Biopharmaceutical Oral Drug Delivery Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Biopharmaceutical Oral Drug Delivery Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Biopharmaceutical Oral Drug Delivery Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Biopharmaceutical Oral Drug Delivery Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Biopharmaceutical Oral Drug Delivery Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Biopharmaceutical Oral Drug Delivery Sales by Country (2027-2032) & (k units) Table 58. Global Biopharmaceutical Oral Drug Delivery Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Biopharmaceutical Oral Drug Delivery Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Biopharmaceutical Oral Drug Delivery Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Biopharmaceutical Oral Drug Delivery Revenue Market Share by Region (2021-2026) Table 62. Global Biopharmaceutical Oral Drug Delivery Revenue Market Share by Region (2027-2032) Table 63. Sanofi Company Information Table 64. Sanofi Business Overview Table 65. Sanofi Biopharmaceutical Oral Drug Delivery Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Sanofi Biopharmaceutical Oral Drug Delivery Product Portfolio Table 67. Sanofi Recent Development Table 68. Novartis Company Information Table 69. Novartis Business Overview Table 70. Novartis Biopharmaceutical Oral Drug Delivery Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Novartis Biopharmaceutical Oral Drug Delivery Product Portfolio Table 72. Novartis Recent Development Table 73. Novo Nordisk Company Information Table 74. Novo Nordisk Business Overview Table 75. Novo Nordisk Biopharmaceutical Oral Drug Delivery Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Novo Nordisk Biopharmaceutical Oral Drug Delivery Product Portfolio Table 77. Novo Nordisk Recent Development Table 78. Pfizer Company Information Table 79. Pfizer Business Overview Table 80. Pfizer Biopharmaceutical Oral Drug Delivery Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Pfizer Biopharmaceutical Oral Drug Delivery Product Portfolio Table 82. Pfizer Recent Development Table 83. Amgen Company Information Table 84. Amgen Business Overview Table 85. Amgen Biopharmaceutical Oral Drug Delivery Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Amgen Biopharmaceutical Oral Drug Delivery Product Portfolio Table 87. Amgen Recent Development Table 88. AbbVie Company Information Table 89. AbbVie Business Overview Table 90. AbbVie Biopharmaceutical Oral Drug Delivery Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. AbbVie Biopharmaceutical Oral Drug Delivery Product Portfolio Table 92. AbbVie Recent Development Table 93. Kemwell Bipharma Company Information Table 94. Kemwell Bipharma Business Overview Table 95. Kemwell Bipharma Biopharmaceutical Oral Drug Delivery Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Kemwell Bipharma Biopharmaceutical Oral Drug Delivery Product Portfolio Table 97. Kemwell Bipharma Recent Development Table 98. F. Hoffman-La Roche Company Information Table 99. F. Hoffman-La Roche Business Overview Table 100. F. Hoffman-La Roche Biopharmaceutical Oral Drug Delivery Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. F. Hoffman-La Roche Biopharmaceutical Oral Drug Delivery Product Portfolio Table 102. F. Hoffman-La Roche Recent Development Table 103. Catalent Company Information Table 104. Catalent Business Overview Table 105. Catalent Biopharmaceutical Oral Drug Delivery Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Catalent Biopharmaceutical Oral Drug Delivery Product Portfolio Table 107. Catalent Recent Development Table 108. Biocon Company Information Table 109. Biocon Business Overview Table 110. Biocon Biopharmaceutical Oral Drug Delivery Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Biocon Biopharmaceutical Oral Drug Delivery Product Portfolio Table 112. Biocon Recent Development Table 113. Key Raw Materials Table 114. Raw Materials Key Suppliers Table 115. Biopharmaceutical Oral Drug Delivery Distributors List Table 116. Biopharmaceutical Oral Drug Delivery Customers List Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Biopharmaceutical Oral Drug Delivery Product Image Figure 2. Global Biopharmaceutical Oral Drug Delivery Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biopharmaceutical Oral Drug Delivery Market Size (2021-2032) & (US$ Million) Figure 4. Global Biopharmaceutical Oral Drug Delivery Sales (2021-2032) & (k units) Figure 5. Global Biopharmaceutical Oral Drug Delivery Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Biopharmaceutical Oral Drug Delivery Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Normally Protein (Antibodies) Image Figure 9. Nucleic Acids (DNA, RNA Or Oligonucleotides) Image Figure 10. Global Biopharmaceutical Oral Drug Delivery Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Biopharmaceutical Oral Drug Delivery Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Biopharmaceutical Oral Drug Delivery Sales Market Share by Type (2021-2032) Figure 13. Global Biopharmaceutical Oral Drug Delivery Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Biopharmaceutical Oral Drug Delivery Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Biopharmaceutical Oral Drug Delivery Revenue Market Share by Type (2021-2032) Figure 16. Retail Pharmacy Image Figure 17. Hospital Pharmacy Image Figure 18. Specialty Pharmacy Image Figure 19. Global Biopharmaceutical Oral Drug Delivery Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Biopharmaceutical Oral Drug Delivery Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Biopharmaceutical Oral Drug Delivery Sales Market Share by Application (2021-2032) Figure 22. Global Biopharmaceutical Oral Drug Delivery Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Biopharmaceutical Oral Drug Delivery Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Biopharmaceutical Oral Drug Delivery Revenue Market Share by Application (2021-2032) Figure 25. North America Biopharmaceutical Oral Drug Delivery Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Biopharmaceutical Oral Drug Delivery Sales Market Share by Country (2021-2032) Figure 27. U.S. Biopharmaceutical Oral Drug Delivery Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Biopharmaceutical Oral Drug Delivery Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Biopharmaceutical Oral Drug Delivery Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Biopharmaceutical Oral Drug Delivery Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Biopharmaceutical Oral Drug Delivery Sales Market Share by Country (2021-2032) Figure 32. Germany Biopharmaceutical Oral Drug Delivery Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Biopharmaceutical Oral Drug Delivery Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Biopharmaceutical Oral Drug Delivery Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Biopharmaceutical Oral Drug Delivery Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Biopharmaceutical Oral Drug Delivery Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Biopharmaceutical Oral Drug Delivery Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Biopharmaceutical Oral Drug Delivery Sales Market Share by Country (2021-2032) Figure 39. China Biopharmaceutical Oral Drug Delivery Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Biopharmaceutical Oral Drug Delivery Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Biopharmaceutical Oral Drug Delivery Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Biopharmaceutical Oral Drug Delivery Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Biopharmaceutical Oral Drug Delivery Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Biopharmaceutical Oral Drug Delivery Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Biopharmaceutical Oral Drug Delivery Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Biopharmaceutical Oral Drug Delivery Sales Market Share by Country (2021-2032) Figure 47. Brazil Biopharmaceutical Oral Drug Delivery Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Biopharmaceutical Oral Drug Delivery Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Biopharmaceutical Oral Drug Delivery Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Biopharmaceutical Oral Drug Delivery Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Biopharmaceutical Oral Drug Delivery Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Biopharmaceutical Oral Drug Delivery Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Biopharmaceutical Oral Drug Delivery Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Biopharmaceutical Oral Drug Delivery Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Biopharmaceutical Oral Drug Delivery Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Biopharmaceutical Oral Drug Delivery Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Biopharmaceutical Oral Drug Delivery Revenue (2021-2032) & (US$ Million) Figure 58. North America Biopharmaceutical Oral Drug Delivery Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Biopharmaceutical Oral Drug Delivery Revenue (2021-2032) & (US$ Million) Figure 60. Europe Biopharmaceutical Oral Drug Delivery Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Biopharmaceutical Oral Drug Delivery Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Biopharmaceutical Oral Drug Delivery Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Biopharmaceutical Oral Drug Delivery Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Biopharmaceutical Oral Drug Delivery Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Biopharmaceutical Oral Drug Delivery Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Biopharmaceutical Oral Drug Delivery Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Normally Protein (Antibodies)
  • Nucleic Acids (DNA, RNA Or Oligonucleotides)
Applications
  • Retail Pharmacy
  • Hospital Pharmacy
  • Specialty Pharmacy
Companies covered
  • Sanofi
  • Novartis
  • Novo Nordisk
  • Pfizer
  • Amgen
  • AbbVie
  • Kemwell Bipharma
  • F. Hoffman-La Roche
  • Catalent
  • Biocon

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Biopharmaceutical Oral Drug Delivery Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Biopharmaceutical Oral Drug Delivery Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Biopharmaceutical Oral Drug Delivery Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Biopharmaceutical Oral Drug Delivery Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Biopharmaceutical Oral Drug Delivery Market Dynamics
  1. 2.1 Biopharmaceutical Oral Drug Delivery Industry Trends
  2. 2.2 Biopharmaceutical Oral Drug Delivery Industry Drivers
  3. 2.3 Biopharmaceutical Oral Drug Delivery Industry Opportunities and Challenges
  4. 2.4 Biopharmaceutical Oral Drug Delivery Industry Restraints
3 Biopharmaceutical Oral Drug Delivery Market by Manufacturers
  1. 3.1 Global Biopharmaceutical Oral Drug Delivery Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Biopharmaceutical Oral Drug Delivery Sales by Manufacturers (2021-2026)
  3. 3.3 Global Biopharmaceutical Oral Drug Delivery Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Biopharmaceutical Oral Drug Delivery Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Biopharmaceutical Oral Drug Delivery Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Biopharmaceutical Oral Drug Delivery Manufacturers, Product Type & Application
  7. 3.7 Global Biopharmaceutical Oral Drug Delivery Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Biopharmaceutical Oral Drug Delivery Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Biopharmaceutical Oral Drug Delivery Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Biopharmaceutical Oral Drug Delivery Tier 1, Tier 2, and Tier 3
4 Biopharmaceutical Oral Drug Delivery Market by Type
  1. 4.1 Biopharmaceutical Oral Drug Delivery Type Introduction
  2. 4.1.1 Normally Protein (Antibodies)
  3. 4.1.2 Nucleic Acids (DNA, RNA Or Oligonucleotides)
  4. 4.2 Global Biopharmaceutical Oral Drug Delivery Sales by Type
  5. 4.2.1 Global Biopharmaceutical Oral Drug Delivery Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Biopharmaceutical Oral Drug Delivery Sales by Type (2021-2032)
  7. 4.2.3 Global Biopharmaceutical Oral Drug Delivery Sales Market Share by Type (2021-2032)
  8. 4.3 Global Biopharmaceutical Oral Drug Delivery Revenue by Type
  9. 4.3.1 Global Biopharmaceutical Oral Drug Delivery Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Biopharmaceutical Oral Drug Delivery Revenue by Type (2021-2032)
  11. 4.3.3 Global Biopharmaceutical Oral Drug Delivery Revenue Market Share by Type (2021-2032)
5 Biopharmaceutical Oral Drug Delivery Market by Application
  1. 5.1 Biopharmaceutical Oral Drug Delivery Application Introduction
  2. 5.1.1 Retail Pharmacy
  3. 5.1.2 Hospital Pharmacy
  4. 5.1.3 Specialty Pharmacy
  5. 5.2 Global Biopharmaceutical Oral Drug Delivery Sales by Application
  6. 5.2.1 Global Biopharmaceutical Oral Drug Delivery Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Biopharmaceutical Oral Drug Delivery Sales by Application (2021-2032)
  8. 5.2.3 Global Biopharmaceutical Oral Drug Delivery Sales Market Share by Application (2021-2032)
  9. 5.3 Global Biopharmaceutical Oral Drug Delivery Revenue by Application
  10. 5.3.1 Global Biopharmaceutical Oral Drug Delivery Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Biopharmaceutical Oral Drug Delivery Revenue by Application (2021-2032)
  12. 5.3.3 Global Biopharmaceutical Oral Drug Delivery Revenue Market Share by Application (2021-2032)
6 Global Biopharmaceutical Oral Drug Delivery Sales by Region
  1. 6.1 Global Biopharmaceutical Oral Drug Delivery Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Biopharmaceutical Oral Drug Delivery Sales by Region (2021-2032)
  3. 6.2.1 Global Biopharmaceutical Oral Drug Delivery Sales by Region (2021-2026)
  4. 6.2.2 Global Biopharmaceutical Oral Drug Delivery Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Biopharmaceutical Oral Drug Delivery Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Biopharmaceutical Oral Drug Delivery Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Biopharmaceutical Oral Drug Delivery Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Biopharmaceutical Oral Drug Delivery Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Biopharmaceutical Oral Drug Delivery Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Biopharmaceutical Oral Drug Delivery Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Biopharmaceutical Oral Drug Delivery Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Biopharmaceutical Oral Drug Delivery Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Biopharmaceutical Oral Drug Delivery Revenue by Region
  1. 7.1 Global Biopharmaceutical Oral Drug Delivery Revenue by Region
  2. 7.1.1 Global Biopharmaceutical Oral Drug Delivery Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Biopharmaceutical Oral Drug Delivery Revenue by Region (2021-2026)
  4. 7.1.3 Global Biopharmaceutical Oral Drug Delivery Revenue by Region (2027-2032)
  5. 7.1.4 Global Biopharmaceutical Oral Drug Delivery Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Biopharmaceutical Oral Drug Delivery Revenue (2021-2032)
  8. 7.2.2 North America Biopharmaceutical Oral Drug Delivery Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Biopharmaceutical Oral Drug Delivery Revenue (2021-2032)
  11. 7.3.2 Europe Biopharmaceutical Oral Drug Delivery Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Biopharmaceutical Oral Drug Delivery Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Biopharmaceutical Oral Drug Delivery Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Biopharmaceutical Oral Drug Delivery Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Biopharmaceutical Oral Drug Delivery Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Biopharmaceutical Oral Drug Delivery Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Biopharmaceutical Oral Drug Delivery Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 Novartis
  8. 8.2.1 Novartis Company Information
  9. 8.2.2 Novartis Business Overview
  10. 8.2.3 Novartis Biopharmaceutical Oral Drug Delivery Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Novartis Biopharmaceutical Oral Drug Delivery Product Portfolio
  12. 8.2.5 Novartis Recent Developments
  13. 8.3 Novo Nordisk
  14. 8.3.1 Novo Nordisk Company Information
  15. 8.3.2 Novo Nordisk Business Overview
  16. 8.3.3 Novo Nordisk Biopharmaceutical Oral Drug Delivery Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Novo Nordisk Biopharmaceutical Oral Drug Delivery Product Portfolio
  18. 8.3.5 Novo Nordisk Recent Developments
  19. 8.4 Pfizer
  20. 8.4.1 Pfizer Company Information
  21. 8.4.2 Pfizer Business Overview
  22. 8.4.3 Pfizer Biopharmaceutical Oral Drug Delivery Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer Biopharmaceutical Oral Drug Delivery Product Portfolio
  24. 8.4.5 Pfizer Recent Developments
  25. 8.5 Amgen
  26. 8.5.1 Amgen Company Information
  27. 8.5.2 Amgen Business Overview
  28. 8.5.3 Amgen Biopharmaceutical Oral Drug Delivery Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Amgen Biopharmaceutical Oral Drug Delivery Product Portfolio
  30. 8.5.5 Amgen Recent Developments
  31. 8.6 AbbVie
  32. 8.6.1 AbbVie Company Information
  33. 8.6.2 AbbVie Business Overview
  34. 8.6.3 AbbVie Biopharmaceutical Oral Drug Delivery Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 AbbVie Biopharmaceutical Oral Drug Delivery Product Portfolio
  36. 8.6.5 AbbVie Recent Developments
  37. 8.7 Kemwell Bipharma
  38. 8.7.1 Kemwell Bipharma Company Information
  39. 8.7.2 Kemwell Bipharma Business Overview
  40. 8.7.3 Kemwell Bipharma Biopharmaceutical Oral Drug Delivery Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Kemwell Bipharma Biopharmaceutical Oral Drug Delivery Product Portfolio
  42. 8.7.5 Kemwell Bipharma Recent Developments
  43. 8.8 F. Hoffman-La Roche
  44. 8.8.1 F. Hoffman-La Roche Company Information
  45. 8.8.2 F. Hoffman-La Roche Business Overview
  46. 8.8.3 F. Hoffman-La Roche Biopharmaceutical Oral Drug Delivery Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 F. Hoffman-La Roche Biopharmaceutical Oral Drug Delivery Product Portfolio
  48. 8.8.5 F. Hoffman-La Roche Recent Developments
  49. 8.9 Catalent
  50. 8.9.1 Catalent Company Information
  51. 8.9.2 Catalent Business Overview
  52. 8.9.3 Catalent Biopharmaceutical Oral Drug Delivery Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Catalent Biopharmaceutical Oral Drug Delivery Product Portfolio
  54. 8.9.5 Catalent Recent Developments
  55. 8.10 Biocon
  56. 8.10.1 Biocon Company Information
  57. 8.10.2 Biocon Business Overview
  58. 8.10.3 Biocon Biopharmaceutical Oral Drug Delivery Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Biocon Biopharmaceutical Oral Drug Delivery Product Portfolio
  60. 8.10.5 Biocon Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Biopharmaceutical Oral Drug Delivery Value Chain Analysis
  2. 9.1.1 Biopharmaceutical Oral Drug Delivery Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Biopharmaceutical Oral Drug Delivery Production Mode & Process
  6. 9.2 Biopharmaceutical Oral Drug Delivery Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Biopharmaceutical Oral Drug Delivery Distributors
  9. 9.2.3 Biopharmaceutical Oral Drug Delivery Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst